ORIC Oric Pharmaceuticals

• None no insider bought on the open market
• None no sales outside a trading plan
• $2.5M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Dominic Piscitelli CFO
   Planned sale
   $189K 14,000 shares at $13.53 17% of stake
   Traded Oct 20 Filed Oct 21
   ↗
3. Richard A. Heyman Director
   Planned sale
   $87K 6,700 shares at $12.91
   Traded Oct 1 Filed Oct 2
   ↗
4. Dominic Piscitelli CFO
   Planned sale
   $181K 13,400 shares at $13.53 16% of stake
   Traded Sep 28 Filed Sep 29
   ↗
5. Dominic Piscitelli CFO
   Planned sale
   $8,103 600 shares at $13.50 0.9% of stake
   Traded Sep 24 Filed Sep 25
   ↗
6. Dominic Piscitelli CFO
   Planned sale
   $1.1M 77,000 shares at $13.69 52% of stake
   Traded Aug 26 Filed Aug 28
   ↗
7. Richard A. Heyman Director
   Planned sale
   $157K 13,100 shares at $12.02
   Traded Jul 24 Filed Jul 28
   ↗
8. Richard A. Heyman Director
   Planned sale
   $3,600 300 shares at $12.00 0.1% of stake
   Traded Jul 6 Filed Jul 8
   ↗
9. Dominic Piscitelli CFO
   Planned sale
   $703K 52,000 shares at $13.51 43% of stake
   Traded Feb 24 Filed Feb 26
   ↗
10. Richard A. Heyman Director
    Planned sale
    $80K 6,700 shares at $12.00
    Traded Jan 16 Filed Jan 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises and 3 sales to cover taxes.